These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2118430)

  • 1. Molecular biologic modification of plasminogen activators. An artful science.
    Loscalzo J
    Circulation; 1990 Sep; 82(3):1062-3. PubMed ID: 2118430
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of new thrombolytic enzymes by gene technology--with special references to t-PA, scu-PA, protein C].
    Ueshima S
    Nihon Rinsho; 1989 Apr; 47(4):901-9. PubMed ID: 2501540
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving natural principles with genetic engineering: TNK-tissue plasminogen activator.
    Werner RG
    Arzneimittelforschung; 2001; 51(6):516-20. PubMed ID: 11455685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology of plasminogen activators: what are the clinical implications of drug design?
    Smalling RW
    Am J Cardiol; 1996 Dec; 78(12A):2-7. PubMed ID: 8990404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator and seizures: a clot-buster's secret life.
    Pawlak R; Strickland S
    J Clin Invest; 2002 Jun; 109(12):1529-31. PubMed ID: 12070298
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thrombolysis using tissue-type plasminogen activator and pro-urokinase: synergism; mutants and hybrids].
    Páramo JA; Fernández FJ; Cuesta B; Paloma MJ; Rocha E
    Sangre (Barc); 1989 Aug; 34(4):297-9. PubMed ID: 2505395
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasminogen activators and thrombolytic therapy].
    Taran LD
    Biomed Khim; 2005; 51(3):248-62. PubMed ID: 16104388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53.
    Kunz C; Pebler S; Otte J; von der Ahe D
    Nucleic Acids Res; 1995 Sep; 23(18):3710-7. PubMed ID: 7479001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
    Nelles L; Lijnen HR; Van Nuffelen A; Demarsin E; Collen D
    Thromb Haemost; 1990 Aug; 64(1):53-60. PubMed ID: 2148847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal cell death and tPA.
    Tsirka SE; Rogove AD; Strickland S
    Nature; 1996 Nov; 384(6605):123-4. PubMed ID: 8906786
    [No Abstract]   [Full Text] [Related]  

  • 11. Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.
    Quax PH; van Leeuwen RT; Verspaget HW; Verheijen JH
    Cancer Res; 1990 Mar; 50(5):1488-94. PubMed ID: 2105839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of plasminogen activators in the nucleus accumbens enhances cocaine-, amphetamine- and morphine-induced reward and behavioral sensitization.
    Bahi A; Dreyer JL
    Genes Brain Behav; 2008 Mar; 7(2):244-56. PubMed ID: 17680802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
    Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD
    Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical, pharmacologic and clinical properties of new thrombolytic agents].
    Gulba DC
    Internist (Berl); 1996 Jun; 37(6):552-66. PubMed ID: 8767988
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos.
    Sappino AP; Huarte J; Belin D; Vassalli JD
    J Cell Biol; 1989 Nov; 109(5):2471-9. PubMed ID: 2509486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.
    Medcalf RL; Van den Berg E; Schleuning WD
    J Cell Biol; 1988 Mar; 106(3):971-8. PubMed ID: 3126194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and clinical impact of the unique molecular structure of a new plasminogen activator.
    Smalling RW
    Eur Heart J; 1997 Dec; 18 Suppl F():F11-6. PubMed ID: 9447335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological properties of hybrid plasminogen activators.
    Hung PP; Wilhelm J; Kalyan NK; Cheng SM; James HL; Nachowiak D; Weinheimer CJ; Sobel BE; Bergmann SR; Lee SG
    Adv Exp Med Biol; 1990; 281():201-8. PubMed ID: 2129369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and regulation of plasminogen activators, plasminogen activator inhibitor type-1, and steroidogenic acute regulatory protein in the rhesus monkey corpus luteum.
    Liu K; Feng Q; Gao HJ; Hu ZY; Zou RJ; Li YC; Liu YX
    Endocrinology; 2003 Aug; 144(8):3611-7. PubMed ID: 12865343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.